Bruker Cellular Analysis Competitors and Similar CompaniesClear all
Sangamo Therapeutics's competitors and similar companies include Spark Therapeutics.
 Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. | ||
Founding Date | Founding Date 1995 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Philadelphia, US HQ |
Employees | Employees 35417% increase | Employees 36817% increase |
Valuation ($) | Valuation ($) 416.4 m | Valuation ($) 4.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $64.7m (FY, 2018) |
Net income | Net income ($122.9m) (FY, 2025) | Net income ($78.8m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 74.2m | Total funding raised $ 122.8m |
For sources of this data, please see the company profile
View Company Profiles
Spark Therapeutics
HQ
Philadelphia, US
Employees
368↑ 17% increase
Spark Therapeutics is a gene therapy company.
View company